OtherGastrointestinal, Hepatic, Pulmonary, and Renal
JNJ-17156516 (3-[5-(3,4-dichloro-phenyl)-1-(4-methoxy-phenyl)-1H-pyrazol-3-yl]-2-m-tolyl-propionate) a novel, potent and selective CCK1 receptor antagonist. In vitro and in vivo pharmacological comparison with dexloxiglumide
Magda F Morton, Terrance Barrett, Wen Yan, Jamie M Freedman, Guy Lagaud, Clodagh E Prendergast, Veronica Moreno, Jayashree Pyati, Katherine Figueroa, Lina Li, Xiaodong Wu, Michele Rizzolio, James G Breitenbucher, Kelly McClure and Nigel P Shankley
Journal of Pharmacology and Experimental Therapeutics August 7, 2007, DOI: https://doi.org/10.1124/jpet.107.124578